EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease

Nitesh Nerlekar, Sheran A Vasanthakumar, Kristyn Whitmore, Cheng Hwee Soh, Jasmine Chan, Vinay Goel, Jacqueline Ryan, Catherine Jones, Tony Stanton, Geoffrey Mitchell, Andrew Tonkin, Gerald F Watts und 3 weitere

JAMA · 22.04.2025 · 333 (16) · 1403

DOI: 10.1001/jama.2025.0584 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA, erschienen am 22.04.2025. Verfasst von Nitesh Nerlekar und 14 weiteren Autor:innen. Beteiligte Einrichtung: Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Coronary Artery Disease, Coronary Vessels, Plaque, Atherosclerotic, Primary Prevention. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Coronary artery calcium (CAC) scoring provides prognostic information, especially in patients at intermediate risk for coronary artery disease (CAD). However, the benefit of combining CAC score with a primary prevention strategy has not been tested in a randomized trial.

Objective

To assess whether combining the CAC score with a prevention strategy can be used to limit plaque progression in intermediate-risk patients with a family history of premature CAD. Design, Setting, and Participants Prospective, randomized, open-blinded end point clinical trial in 7 hospitals across Australia (between 2013 and 2020; the last date of follow-up was June 5, 2021). Asymptomatic people aged 40 to 70 years with a first-degree relative with CAD onset at younger than 60 years old or second-degree relative with onset at younger than 50 years old were recruited from the community.

Interventions

Intermediate-risk participants underwent CAC scoring. Those with a CAC score greater than 0 but less than 400 underwent coronary computed tomography angiography (CCTA) and were randomized to CAC score–informed prevention or usual care. Main Outcomes and Measures Follow-up CCTA was obtained at 3 years, with plaque volume measured by an independent core laboratory. The primary outcome was total plaque volume, with further analysis for calcified and noncalcified plaque volume.

Results

This study included 365 participants (mean [SD] age, 58 [6] years; 57.5% male); 179 in the CAC score–informed and 186 in the usual care groups. Compared with usual care, the CAC score–informed group showed a sustained reduction in total (mean [SD], −3 [31] mg/dL vs −56 [38] mg/dL; P < .001) and LDL (mean [SD], −2 [31] vs −51 [36] mg/dL; P < .001) cholesterol levels at 3 years, which was associated with a reduction in pooled cohort equation risk calculation (mean [SD], 2.1% [2.9%] vs 0.5% [2.9%]; P < .001). Plaque progression was greater in usual care than CAC score–informed participants for total plaque volume (mean [SD], 24.9 [37.7] mm 3 vs 15.4 [30.9] mm 3 ; P = .009), noncalcified plaque volume (mean [SD], 15.7 [32.2] mm 3 vs 5.6 [28.5] mm 3 ; P = .002), and fibrofatty and necrotic core plaque volume (mean [SD], 4.5 [25.8] mm 3 vs −0.8 [12.6] mm 3 ; P = .02). These plaque volume changes were independent of other risk factors including baseline plaque volume, blood pressure, and lipid profile. Conclusions and Relevance The combination of CAC score with a primary prevention strategy in intermediate-risk patients with a family history of CAD was associated with reduction of atherogenic lipids and slower plaque progression compared with usual care. These data support the use of CAC score to assist intensive preventive strategies in intermediate-risk patients. Trial Registration anzctr.org.au Identifier: ACTRN12614001294640

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseCoronary VesselsPlaque, AtheroscleroticPrimary PreventionVascular CalcificationFemaleHumansMaleMiddle AgedComputed Tomography AngiographyCoronary AngiographyDisease ProgressionProspective StudiesRisk AssessmentAustraliaFollow-Up StudiesAsymptomatic Diseases

Autor:innen und Institutionen

  • Baker Heart and Diabetes Research Institute, Melbourne, Victoria, Australia.
  • Victorian Heart Hospital, Melbourne, Victoria, Australia.
  • Victorian Heart Institute, Monash University, Melbourne, Victoria, Australia.
  • Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
  • Royal Perth Hospital and School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
  • Regional Imaging, Hobart, Tasmania, Australia.

Zitieren

APA

Nerlekar, N., Vasanthakumar, S. A., Whitmore, K., Soh, C. H., Chan, J., Goel, V., Ryan, J., Jones, C., Stanton, T., Mitchell, G., Tonkin, A., Watts, G. F., Nicholls, S. J., Marwick, T. H., & Coronary Artery Calcium Score: Use to Guide Management of Hereditary Coronary Artery Disease (CAUGHT-CAD) Investigators (2025). Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease. JAMA, 333(16), 1403. https://doi.org/10.1001/jama.2025.0584

Vancouver

Nerlekar N, Vasanthakumar SA, Whitmore K, Soh CH, Chan J, Goel V, et al. Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease. JAMA. 2025;333(16):1403. doi:10.1001/jama.2025.0584

BibTeX
@article{Nerlekar2025,
  author = {Nerlekar, Nitesh and Vasanthakumar, Sheran A and Whitmore, Kristyn and Soh, Cheng Hwee and Chan, Jasmine and Goel, Vinay and Ryan, Jacqueline and Jones, Catherine and Stanton, Tony and Mitchell, Geoffrey and Tonkin, Andrew and Watts, Gerald F and Nicholls, Stephen J and Marwick, Thomas H and Coronary Artery Calcium Score: Use to Guide Management of Hereditary Coronary Artery Disease (CAUGHT-CAD) Investigators, Coronary Artery Calcium Score: Use to Guide Management of Hereditary Coronary Artery Disease (CAUGHT-CAD) Investigators},
  title = {Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease},
  journal = {JAMA},
  year = {2025},
  volume = {333},
  number = {16},
  pages = {1403},
  doi = {10.1001/jama.2025.0584}
}
Kostenlos starten →